| Dr James F Witko, MD, FCCP | |
|
2210 Wilborn Ave, South Boston, VA 24592-1630 | |
| (434) 575-5864 | |
| (434) 575-8929 |
| Full Name | Dr James F Witko |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 42 Years |
| Location | 2210 Wilborn Ave, South Boston, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427018829 | NPI | - | NPPES |
| 88661 | Other | NC | BC/BS OF NC PROVIDER # |
| 006013899 | Medicaid | VA | |
| 032654 | Other | VA | ANTHEM BC PROVIDER # |
| 2317122 | Other | NC | MEDICARE GROUP # |
| 890556G | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 0101042054 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sentara Halifax Regional Hospital | South boston, VA | Hospital |
| Duke University Hospital | Durham, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pulmonary Associates Of Southside Virginia, Inc | 8628008331 | 5 |
News Archive
Forty-one-year-old Laura Gable has lived her entire life with cerebral palsy, a neurological disorder that appears in infancy or early childhood, and permanently affects body movement and posture.
Naviscan, Inc., the leader in Molecular Breast Imaging (MBI), today announced that Paul J. Mirabella, President and Chief Executive Officer, will be presenting a corporate update at the 4th Annual BIOCOM Investor Conference on October 27, 2009 at 1:00 p.m. being held at Hyatt Regency in La Jolla, California.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the Company's new drug application (NDA) for Zalviso (sufentanil sublingual tablet system).
DiosCURE SE announced a publication in Science describing its core technology of multivalent single-chain antibodies with a unique molecular mode-of-action to inactivate SARS-CoV-2 virions. An international team led by scientists at the University of Bonn developed and characterized the lead candidates, which are exclusively licensed by DiosCURE.
› Verified 9 days ago
| Entity Name | Halifax Regional Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588668842 PECOS PAC ID: 4587572805 Enrollment ID: O20040607000050 |
News Archive
Forty-one-year-old Laura Gable has lived her entire life with cerebral palsy, a neurological disorder that appears in infancy or early childhood, and permanently affects body movement and posture.
Naviscan, Inc., the leader in Molecular Breast Imaging (MBI), today announced that Paul J. Mirabella, President and Chief Executive Officer, will be presenting a corporate update at the 4th Annual BIOCOM Investor Conference on October 27, 2009 at 1:00 p.m. being held at Hyatt Regency in La Jolla, California.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the Company's new drug application (NDA) for Zalviso (sufentanil sublingual tablet system).
DiosCURE SE announced a publication in Science describing its core technology of multivalent single-chain antibodies with a unique molecular mode-of-action to inactivate SARS-CoV-2 virions. An international team led by scientists at the University of Bonn developed and characterized the lead candidates, which are exclusively licensed by DiosCURE.
› Verified 9 days ago
| Entity Name | Pulmonary Associates Of Southside Virginia, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265436117 PECOS PAC ID: 8628008331 Enrollment ID: O20050812000511 |
News Archive
Forty-one-year-old Laura Gable has lived her entire life with cerebral palsy, a neurological disorder that appears in infancy or early childhood, and permanently affects body movement and posture.
Naviscan, Inc., the leader in Molecular Breast Imaging (MBI), today announced that Paul J. Mirabella, President and Chief Executive Officer, will be presenting a corporate update at the 4th Annual BIOCOM Investor Conference on October 27, 2009 at 1:00 p.m. being held at Hyatt Regency in La Jolla, California.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the Company's new drug application (NDA) for Zalviso (sufentanil sublingual tablet system).
DiosCURE SE announced a publication in Science describing its core technology of multivalent single-chain antibodies with a unique molecular mode-of-action to inactivate SARS-CoV-2 virions. An international team led by scientists at the University of Bonn developed and characterized the lead candidates, which are exclusively licensed by DiosCURE.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James F Witko, MD, FCCP 2210 Wilborn Ave, South Boston, VA 24592-1630 Ph: (434) 575-5864 | Dr James F Witko, MD, FCCP 2210 Wilborn Ave, South Boston, VA 24592-1630 Ph: (434) 575-5864 |
News Archive
Forty-one-year-old Laura Gable has lived her entire life with cerebral palsy, a neurological disorder that appears in infancy or early childhood, and permanently affects body movement and posture.
Naviscan, Inc., the leader in Molecular Breast Imaging (MBI), today announced that Paul J. Mirabella, President and Chief Executive Officer, will be presenting a corporate update at the 4th Annual BIOCOM Investor Conference on October 27, 2009 at 1:00 p.m. being held at Hyatt Regency in La Jolla, California.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the Company's new drug application (NDA) for Zalviso (sufentanil sublingual tablet system).
DiosCURE SE announced a publication in Science describing its core technology of multivalent single-chain antibodies with a unique molecular mode-of-action to inactivate SARS-CoV-2 virions. An international team led by scientists at the University of Bonn developed and characterized the lead candidates, which are exclusively licensed by DiosCURE.
› Verified 9 days ago
Dr. Amar A Parikh, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2045 Hamilton Boulevard, South Boston, VA 24592 Phone: 434-572-6565 Fax: 434-572-4322 | |
Dr. Fuad Shatila, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 2232 Willborn Ave, South Boston, VA 24592 Phone: 434-517-3705 | |
Roger W Browne, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 2100 Wilborn Ave, South Boston, VA 24592 Phone: 434-572-6946 Fax: 434-572-6675 | |
Dr. Chad Michael Henry, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2210 Wilborn Ave, South Boston, VA 24592 Phone: 434-517-3827 | |
Richard W Davis, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1627 Seymour Dr, South Boston, VA 24592 Phone: 434-517-0611 Fax: 434-572-6675 | |
Dr. Sherry Lene Hall, M.D Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 2202-a Beechmont Road, South Boston, VA 24592 Phone: 434-575-6300 Fax: 434-575-8300 | |
Suresh Gehan Jayatilaka, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1129 N Main St Ste G, South Boston, VA 24592 Phone: 434-572-8196 Fax: 434-572-8341 |